載入...
The combined presence of CD20+ B cells and PD-L1+ tumor infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome.
PURPOSE: To evaluate protein expression of PD-L1 and CD20 as prognostic biomarkers of patient outcome in inflammatory breast cancer (IBC) samples. METHODS: PD-L1 and CD20 protein expression was measured by immunohistochemistry in 221 pretreatment IBC biopsies. PD-L1 was assessed in tumor cells (PD-L...
Na minha lista:
| 發表在: | Breast Cancer Res Treat |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6173952/ https://ncbi.nlm.nih.gov/pubmed/29858752 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-018-4834-7 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|